It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."

AdvaMed, a medtech industry group made up of medical imaging companies, says tariffs are having a major impact for all vendors. 

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 

In a new poll, more insured adults listed receiving coverage approval for treatment and medications as the single largest burden they face when navigating the U.S. healthcare system than any other issue. KFF found that 47% experienced “denied, delayed or altered” patient care over the last two years. 

Physicians made their plea in in the February issue of the JACR, which is focused on the “Economics of Education,” and meant to spark “dialogue around how radiology education is valued, supported and delivered.” 

E-mails sent to the full workforce at hospitals and health systems are costly due to the time they take away from recipients’ other essential duties and tasks. How costly? Researchers have done the math.